Pilot - Resistance Exercise for Inpatient Treatment in T2D
Launched by RIGSHOSPITALET, DENMARK · Aug 7, 2024
Trial Information
Current as of June 07, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether adding resistance exercise, like weight training, to the care of hospitalized patients with Type 2 Diabetes (T2D) can improve their health. Many patients with T2D spend a lot of time in the hospital and often don't get enough physical activity during their stay, which can worsen their condition. This study will involve 24 hospitalized patients who will either participate in a 30-minute resistance training session each day for four weeks or receive standard care without exercise. Participants will wear devices to monitor their glucose levels and activity throughout the trial.
To be eligible, participants must be at least 18 years old, hospitalized due to an infection, and have a diagnosis of T2D. They should be able to perform basic exercises as outlined in a provided booklet. Certain health conditions, such as severe heart problems or kidney failure, may exclude individuals from joining the study. If participants are discharged from the hospital, they will have the opportunity to continue their exercise training online. This trial aims to understand if exercise can help improve glucose control and overall health for patients with T2D during their hospital stay.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • T2D or prediabetes defined as at least one of the following
- • ICD-10 diagnosis of T2D (DE11.x)
- • HbA1c \> 48 at time of admission
- • Use of type 2 antidiabetic medicine (excluding SGLT2 inhibitors)
- • HbA1c ≥ 42 within 3 months of admission (prediabetes)
- • Hospitalized with an infection
- • Expected residual hospitalization time of at least three days
- • At least 18 years of age
- • Able to perform exercises in the booklet "Syg men sun dog aktiv"
- Exclusion Criteria:
- • Admitted to the hospital more than 5 days ago
- • Unable to give written consent to participate
- • Terminal illness
- • Unstable or new onset angina
- • Ventricular arrhythmia
- • Aortic stenosis
- • Sternotomy in conjunction with the current hospitalization
- • Blood pressure greater than 180/120 mmHg
- • Kidney failure requiring dialysis
- • Unable to follow the 3-stage command of the Mini-Mental State Examination
- • Known allergy or contact dermatitis to tape, and CGMs
About Rigshospitalet, Denmark
Rigshospitalet, located in Copenhagen, Denmark, is one of the leading hospitals in Scandinavia and a prominent center for clinical research and innovation. As a key academic institution affiliated with the University of Copenhagen, Rigshospitalet is dedicated to advancing healthcare through rigorous clinical trials and groundbreaking research across various medical disciplines. The hospital’s commitment to excellence is reflected in its multidisciplinary approach, collaboration with international research networks, and focus on improving patient outcomes through evidence-based practices. With state-of-the-art facilities and a team of highly qualified professionals, Rigshospitalet plays a crucial role in translating scientific discoveries into effective treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, Capitol Region Of Denmark, Denmark
Copenhagen, Capitol Region Of Denmark, Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported